Citadel Advisors - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 46 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 3.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$7,000
-83.3%
33,512
-62.5%
0.00%
Q2 2019$42,000
+250.0%
89,434
+240.4%
0.00%
Q1 2019$12,000
-42.9%
26,271
-61.1%
0.00%
Q4 2018$21,000
-43.2%
67,518
+31.9%
0.00%
Q3 2018$37,000
-7.5%
51,203
-44.4%
0.00%
Q2 2018$40,000
+135.3%
92,117
+181.6%
0.00%
Q1 2018$17,000
-22.7%
32,707
-15.5%
0.00%
Q3 2017$22,000
+4.8%
38,700
+54.2%
0.00%
Q2 2017$21,000
-88.5%
25,100
-81.4%
0.00%
Q1 2017$183,000
+976.5%
134,896
+261.5%
0.00%
Q4 2016$17,000
+142.9%
37,317
+249.3%
0.00%
Q2 2016$7,000
-68.2%
10,683
-59.7%
0.00%
Q1 2016$22,000
+22.2%
26,537
+51.3%
0.00%
Q4 2015$18,000
+350.0%
17,540
+436.1%
0.00%
Q3 2015$4,000
+300.0%
3,272
+965.8%
0.00%
Q2 2015$1,000
-88.9%
307
-93.9%
0.00%
Q1 2015$9,000
-89.9%
5,032
-89.6%
0.00%
Q4 2014$89,000
+140.5%
48,446
+377.7%
0.00%
Q2 2014$37,000
-47.1%
10,141
-33.6%
0.00%
Q1 2014$70,000
-11.4%
15,269
-24.9%
0.00%
Q4 2013$79,000
+1028.6%
20,337
+1312.3%
0.00%
Q3 2013$7,000
-91.1%
1,440
-91.1%
0.00%
Q2 2013$79,00016,1630.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Camber Capital Management LP 13,275,000$8,496,0000.41%
Broadfin Capital, LLC 2,025,268$1,296,0000.13%
Baillie Gifford 6,361,364$4,071,0000.01%
Spark Investment Management LLC 73,200$46,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$194,0000.00%
WEDBUSH SECURITIES INC 18,000$12,0000.00%
Financial Architects, Inc 10,000$6,0000.00%
Psagot Value Holdings Ltd. 22,050$14,0000.00%
BARCLAYS PLC 629,591$403,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 800,900$513,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders